Gary F. Baxter
Gary F. Baxter
Professor of Pharmacology, School of Pharmacy & Pharmaceutical Sciences, Cardiff university, UK
Verifierad e-postadress på cardiff.ac.uk
Titel
Citeras av
Citeras av
År
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning
P Ferdinandy, R Schulz, GF Baxter
Pharmacological reviews 59 (4), 418-458, 2007
8762007
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
DJ Hausenloy, HL Maddock, GF Baxter, DM Yellon
Cardiovascular research 55 (3), 534-543, 2002
6902002
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of …
M Ovize, GF Baxter, F Di Lisa, P Ferdinandy, D Garcia-Dorado, ...
Cardiovascular research 87 (3), 406-423, 2010
5812010
Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning
P Ferdinandy, DJ Hausenloy, G Heusch, GF Baxter, R Schulz
Pharmacological reviews 66 (4), 1142-1174, 2014
4782014
Ischaemic preconditioning: present position and future directions
DM Yellon, GF Baxter, D Garcia-Dorado, G Heusch, MS Sumeray
Cardiovascular research 37 (1), 21-33, 1998
4161998
Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia–reperfusion injury
D Johansen, K Ytrehus, GF Baxter
Basic research in cardiology 101 (1), 53-60, 2006
3522006
A “second window of protection” or delayed preconditioning phenomenon: future horizons for myocardial protection?
DM Yellon, GF Baxter
Journal of molecular and cellular cardiology 27 (4), 1023-1034, 1995
3521995
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.
GF Baxter, MS Marber, VC Patel, DM Yellon
Circulation 90 (6), 2993-3000, 1994
3471994
Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels
TJ Pell, GF Baxter, DM Yellon, GM Drew
American Journal of Physiology-Heart and Circulatory Physiology 275 (5 …, 1998
3341998
B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening
SP D'souza, DM Yellon, C Martin, R Schulz, G Heusch, A Onody, ...
American Journal of Physiology-Heart and Circulatory Physiology 284 (5 …, 2003
2942003
Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium
GF Baxter, FM Goma, DM Yellon
Basic research in cardiology 92 (3), 159-167, 1997
2881997
Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin
D Roy, J Quiles, DC Gaze, P Collinson, JC Kaski, GF Baxter
Heart 92 (1), 113-114, 2006
2742006
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
DJ Hausenloy, G Baxter, R Bell, HE Bøtker, SM Davidson, J Downey, ...
Basic research in cardiology 105 (6), 677-686, 2010
2612010
Autocrine and paracrine actions of natriuretic peptides in the heart
SP D'Souza, M Davis, GF Baxter
Pharmacology & therapeutics 101 (2), 113-129, 2004
2602004
Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury
MM Mocanu, GF Baxter, DM Yellon
British journal of pharmacology 130 (2), 197-200, 2000
2382000
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide
MM Mocanu, HL Maddock, GF Baxter, CL Lawrence, NB Standen, ...
Circulation 103 (25), 3111-3116, 2001
2142001
Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?
DM Yellon, GF Baxter
Heart 83 (4), 381-387, 2000
2142000
Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium
GF Baxter, FM Goma, DM Yellon
British journal of pharmacology 115 (2), 222-224, 1995
2041995
Cyclic GMP and protein kinase‐G in myocardial ischaemia‐reperfusion: opportunities and obstacles for survival signaling
DS Burley, P Ferdinandy, GF Baxter
British journal of pharmacology 152 (6), 855-869, 2007
1862007
Regulation of cardiovascular cell function by hydrogen sulfide (H2S)
DJ Elsey, RC Fowkes, GF Baxter
Cell Biochemistry and Function: Cellular biochemistry and its modulation by …, 2010
1702010
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20